Nalaganje...
Genomics of lethal prostate cancer at diagnosis and castration resistance
The genomics of primary prostate cancer differ from those of metastatic castration-resistant prostate cancer (mCRPC). We studied genomic aberrations in primary prostate cancer biopsies from patients who developed mCRPC, also studying matching, same-patient, diagnostic, and mCRPC biopsies following t...
Shranjeno v:
| izdano v: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108902/ https://ncbi.nlm.nih.gov/pubmed/31874108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI132031 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|